How Close Are We to a Cure? Advances in Gene & Genetic Therapies for PKD

• Understanding why PKD is a dose-dependent disease and how this reshapes therapeutic strategy
• Differentiating emerging genetic therapies from traditional gene therapy approaches
• Exploring patient-centric delivery strategies for targeting kidney cells, including how route of administration impacts safety, tolerability, and access

Speakers:

Christopher Chen

Vice President of Research Programs

PKD Foundation